Home
Market News
Breaking stock market headlines
Earnings Flash
Breaking coverage of earnings reports, forecasts & dividend updates
Trends
Market movers, trading patterns & key market indicators
Disclosures
Official filings & reports from listed Japanese companies
Explorer
Stock lists filtered by fundamental & technical metrics
Cyfuse Biomedical shares surge on report of world-first knee joint regenerative medicine trial in July
Cyfuse Biomedical K.K. <4892> surged at the open. The Nikkei reported on April 19 that Keio University and Fujita Health University will launch a physician-led clinical trial in July to simultaneously repair bone and cartilage in knee joints. Cyfuse, which provides the bio-3D printing technology for the trial, saw its shares buoyed by the report. The project marks the world-first implementation of regenerative medicine using 3D-printed structures created from donor-derived adipose tissue cells for transplantation into affected areas.
Source: MINKABU PRESS
*Translated by generative AI. Click here for the original article.
Related Articles
Imamura Securities hits fresh year-to-date high on 39% net profit surge
ARCHITECTS STUDIO JAPAN rises for third straight session on operating profit forecast
Tokyo market sees 801 decliners against 686 advancers at 11:00 AM
Hong Kong's Hang Seng Index opens up 44.28 points at 26,204.61
FX Summary: Dollar-yen rises toward 159.20 yen as Middle East optimism fades
Tokyo Prime Market sees 838 decliners against 679 advancers at 10:00 AM
Stock in Focus: TOYOTA TSUSHO in focus as African operations drive growth expectations
ADJUVANT shares tumble on forecast for sharp operating profit decline in fiscal 2026
WACOAL shares surge to daily limit on reports of pressure from 3D Investment to sell assets
Kokopelli shares climb as financial institutions adopt BIG ADVANCE GLOBAL platform